cagrisema phase 3 results 2025 semaglutide cagrilintide obesity Updates in Medicine | 🔬 REDEFINE 2: in T2D + Original article link in bio 👥 3a RCT in 1206 adults with T2D (BMI ≥27, HbA1c 7–10%) 💉 Efficacy and safety of co-administered

Most patients weigh factors like the molecule and brand, what theyre being treated for, their insurance situation, and how their body responds to a particular treatment

And one thing that cannot be skipped

Unlike the occasional craving, food noise feels like constant, intrusive thoughts about eating whether youre physically hungry or not

H., Ozeki, M., Juneja, L

The only limiting factors are typically adverse effects that increase with higher doses or the impracticality (physically or financially) of taking excessive amounts of these treatments

Ozempic is FDA-approved for Type 2 Diabetes and cardiovascular risk reduction, not for weight loss